Insider Transactions in Q4 2021 at Rapt Therapeutics, Inc. (RAPT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$79,410
$30.88 P/Share
|
|
Dec 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.3 P/Share
|
|
Dec 03
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.99%
|
$96,000
$32.26 P/Share
|
|
Nov 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$92,680
$35.69 P/Share
|
|
Nov 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.3 P/Share
|
|
Oct 18
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
500
+5.1%
|
$15,000
$30.7 P/Share
|
|
Oct 13
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
400
+4.35%
|
$11,600
$29.69 P/Share
|
|
Oct 13
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.75%
|
$87,000
$29.69 P/Share
|
|
Oct 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$79,410
$30.78 P/Share
|
|
Oct 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.18 P/Share
|